Extrawell Pharmaceutical Holdings Limited (0858.HK)
HKD 0.05
(2.04%)
HKD 0.05
(2.04%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.28 Billion HKD | -10.91% |
| 2022 | 1.44 Billion HKD | 9.7% |
| 2021 | 1.31 Billion HKD | 13.13% |
| 2020 | 1.16 Billion HKD | -8.02% |
| 2019 | 1.26 Billion HKD | 5.82% |
| 2018 | 1.19 Billion HKD | -1.7% |
| 2017 | 1.21 Billion HKD | 3.76% |
| 2016 | 1.17 Billion HKD | 1.02% |
| 2015 | 1.16 Billion HKD | 1.95% |
| 2014 | 1.13 Billion HKD | 58.07% |
| 2013 | 720.34 Million HKD | 0.38% |
| 2012 | 717.61 Million HKD | 4.33% |
| 2011 | 687.8 Million HKD | 3.57% |
| 2010 | 664.09 Million HKD | 1.51% |
| 2009 | 654.21 Million HKD | 1.26% |
| 2008 | 646.05 Million HKD | 4.27% |
| 2007 | 619.57 Million HKD | 4.31% |
| 2006 | 593.98 Million HKD | 3.97% |
| 2005 | 571.32 Million HKD | -3.38% |
| 2004 | 591.29 Million HKD | 11.49% |
| 2003 | 530.33 Million HKD | -11.52% |
| 2002 | 599.36 Million HKD | 57.46% |
| 2001 | 380.65 Million HKD | 86.99% |
| 2000 | 203.56 Million HKD | 15.58% |
| 1999 | 176.13 Million HKD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 1.28 Billion HKD | -10.91% |
| 2023 Q2 | 1.2 Billion HKD | 0.0% |
| 2023 Q4 | 1.28 Billion HKD | 0.0% |
| 2022 Q2 | 1.34 Billion HKD | 0.0% |
| 2022 FY | 1.44 Billion HKD | 9.7% |
| 2022 Q4 | 1.44 Billion HKD | 0.0% |
| 2021 Q2 | 1.25 Billion HKD | 0.0% |
| 2021 Q4 | 1.31 Billion HKD | 0.0% |
| 2021 FY | 1.31 Billion HKD | 13.13% |
| 2020 Q4 | 1.16 Billion HKD | 0.0% |
| 2020 FY | 1.16 Billion HKD | -8.02% |
| 2020 Q2 | 1.34 Billion HKD | 0.0% |
| 2019 FY | 1.26 Billion HKD | 5.82% |
| 2019 Q2 | 1.2 Billion HKD | 0.0% |
| 2019 Q4 | 1.26 Billion HKD | 0.0% |
| 2018 Q2 | 1.18 Billion HKD | 0.0% |
| 2018 Q4 | 1.19 Billion HKD | 0.0% |
| 2018 FY | 1.19 Billion HKD | -1.7% |
| 2017 FY | 1.21 Billion HKD | 3.76% |
| 2017 Q4 | 1.21 Billion HKD | 0.0% |
| 2017 Q2 | 1.19 Billion HKD | 0.0% |
| 2016 Q2 | 1.17 Billion HKD | 0.0% |
| 2016 FY | 1.17 Billion HKD | 1.02% |
| 2016 Q4 | 1.17 Billion HKD | 0.0% |
| 2015 Q1 | 1.09 Billion HKD | -4.11% |
| 2015 Q4 | 1.16 Billion HKD | 0.0% |
| 2015 FY | 1.16 Billion HKD | 1.95% |
| 2015 Q2 | 1.09 Billion HKD | 0.0% |
| 2014 Q1 | 1.41 Billion HKD | 96.22% |
| 2014 FY | 1.13 Billion HKD | 58.07% |
| 2014 Q4 | 1.13 Billion HKD | 0.0% |
| 2014 Q3 | 1.13 Billion HKD | -19.44% |
| 2014 Q2 | 1.41 Billion HKD | 0.0% |
| 2013 Q2 | 1.35 Billion HKD | 0.0% |
| 2013 Q4 | 720.34 Million HKD | 0.0% |
| 2013 Q3 | 720.34 Million HKD | -46.79% |
| 2013 Q1 | 1.35 Billion HKD | 88.66% |
| 2013 FY | 720.34 Million HKD | 0.38% |
| 2012 Q2 | 727.83 Million HKD | 0.0% |
| 2012 Q1 | 727.83 Million HKD | 5.82% |
| 2012 FY | 717.61 Million HKD | 4.33% |
| 2012 Q4 | 717.61 Million HKD | 0.0% |
| 2012 Q3 | 717.61 Million HKD | -1.4% |
| 2011 Q4 | 687.8 Million HKD | 0.0% |
| 2011 FY | 687.8 Million HKD | 3.57% |
| 2011 Q2 | 679.96 Million HKD | 0.0% |
| 2010 FY | 664.09 Million HKD | 1.51% |
| 2010 Q4 | 664.09 Million HKD | 0.0% |
| 2010 Q2 | 686.69 Million HKD | 0.0% |
| 2009 Q4 | 654.21 Million HKD | 0.0% |
| 2009 FY | 654.21 Million HKD | 1.26% |
| 2008 FY | 646.05 Million HKD | 4.27% |
| 2007 FY | 619.57 Million HKD | 4.31% |
| 2006 FY | 593.98 Million HKD | 3.97% |
| 2005 FY | 571.32 Million HKD | -3.38% |
| 2004 FY | 591.29 Million HKD | 11.49% |
| 2003 FY | 530.33 Million HKD | -11.52% |
| 2002 FY | 599.36 Million HKD | 57.46% |
| 2001 FY | 380.65 Million HKD | 86.99% |
| 2000 FY | 203.56 Million HKD | 15.58% |
| 1999 FY | 176.13 Million HKD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -41.844% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 94.283% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | 38.562% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -169.221% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | 55.471% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | 54.477% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | 25.481% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -52.517% |
| SSY Group Limited | 11.96 Billion HKD | 89.243% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | 7.31% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | 63.085% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 99.526% |